Fresh Rounds

Linnaeus Therapeutics, Inc. funding

Linnaeus Therapeutics, Inc., a biotechnology company based in Haddonfield, NJ, filed a Form D with the SEC on February 27, 2026 and reported $4.5M raised of a $10M offering.

Amount raised$4.5M
Offering size$10M
Filed with the SECFebruary 27, 2026
First saleFebruary 17, 2026
IndustryBiotechnology
SecuritiesEquity
LocationHaddonfield, NJ
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far19
Minimum investment$1
Revenue rangeDecline to Disclose

Other health care rounds in New Jersey